tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rahul Sarugaser, 33 are a BUY (89.19%), 4 are a HOLD (10.81%).
Analyst Rahul Sarugaser, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 40.21% that have a potential upside of 53.64% achieved within 135 days.
Rahul Sarugaser’s has documented 64 price targets and ratings displayed on 13 stocks. The coverage is on Consumer Defensive, Technology, Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on QIPT, Quipt Home Medical Corp at 16-May-2024.
Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
The best stock recommendation documented was for DNA (GINKGO BIOWORKS HOLDINGS) at 10/13/2021. The price target of $580 was fulfilled within 6 days with a profit of $170 (41.46%) receiving and performance score of 69.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Aug-2021
$3
$2.55 (566.67%)
$8
4 years 6 months 20 days ago
(01-Apr-2022)
0/2 (0%)
$1.87 (165.49%)
What Year was the first public recommendation made by Rahul Sarugaser?
